J.Jill (JILL)
(Delayed Data from NYSE)
$24.86 USD
+0.64 (2.64%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $24.90 +0.04 (0.16%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.86 USD
+0.64 (2.64%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $24.90 +0.04 (0.16%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Zacks News
J.Jill (JILL) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
J.Jill (JILL) delivered earnings and revenue surprises of 11.70% and 0.07%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
J.Jill Gears Up to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
JILL has been witnessing selling, general and administrative expenses for a while now. It anticipates net sales to remain flat to decline 3% for the second quarter of fiscal 2024.
Genesco (GCO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Genesco (GCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gap (GAP) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Gap (GAP) delivered earnings and revenue surprises of 38.46% and 2.93%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: J.Jill (JILL) Q2 Earnings Expected to Decline
by Zacks Equity Research
J.Jill (JILL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is J.Jill (JILL) Outperforming Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Here is how J.Jill (JILL) and El Pollo Loco Holdings (LOCO) have performed compared to their sector so far this year.
Is J.Jill (JILL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
J.Jill (JILL) Surges 5.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
J.Jill (JILL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Recent Price Trend in J.Jill (JILL) is Your Friend, Here's Why
by Zacks Equity Research
J.Jill (JILL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Should Value Investors Buy J.Jill (JILL) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
Bull of the Day: J.Jill (JILL)
by Tracey Ryniec
This women's apparel retailer is near 5-year highs.
Are Investors Undervaluing J.Jill (JILL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include GigaCloud Technology, J.Jill, Adtalem Global Education and Virco Manufacturing
by Zacks Equity Research
GigaCloud Technology, J.Jill, Adtalem Global Education and Virco Manufacturing are part of the Zacks Screen of the Week article.
5 Solid Stocks to Buy as Retail Sector Aims for a Rebound
by Ritujay Ghosh
Easing inflation is helping the retail sector stage a recovery, which is likely to benefit stocks like The Gap, Inc. (GPS), Canada Goose Holdings Inc. (GOOS), Walmart, Inc. (WMT), JD.com, Inc. (JD) and J.Jill, Inc. (JILL).
The Zacks Analyst Blog Highlights The Gap, Abercrombie & Fitch, J.Jill, Canada Goose and Stitch Fix
by Santanu Roy
The Gap, Abercrombie & Fitch, J.Jill, Canada Goose and Stitch Fix are part of the Zacks top Analyst Blog.
4 Solid Net Profit Margin Stocks to Buy for Better Returns
by Anirudha Bhagat
Here we present four top-ranked stocks, GCT, JILL, ATGE and VIRC, with solid net profit margins that can contribute toward making a strong portfolio.
5 Must-Buy Retailers With Solid Earnings Estimate Revisions
by Nalak Das
We have narrowed our search to five retail - apparel and shoe industry stocks that have strong potential for 2024. These stocks are: ANF, JILL, GPS, SFIX, GOOS.
Zacks.com featured highlights include J.Jill, KNOT Offshore, Virco, Dycom and Kirby
by Zacks Equity Research
J.Jill, KNOT Offshore, Virco, Dycom and Kirby have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are JILL, KNOP, VIRC, DY, KEX.
Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol
by Zacks Equity Research
J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.
J.Jill (JILL) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
J.Jill (JILL) first-quarter 2024 results reflect careful planning, disciplined inventory management and a focus on full-price selling.
3 Stocks Backed by High Efficiency to Boost Portfolio Returns
by Santanu Roy
Invest in stocks of J.Jill (JILL), Option Care Health (OPCH) and Amphenol (APH) to tap their high-efficiency levels.
J.Jill (JILL) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
J.Jill (JILL) delivered earnings and revenue surprises of 7.02% and 0.95%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Buy J.Jill (JILL) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.